In the News

The US Food and Drug Administration (FDA) approved burosumab-twza (Crysvita) injection to treat patients aged 2 years and older with tumour-induced osteomalacia (TIO). “Treatment for TIO focuses on identifying and removing the tumour that causes the disease; however, when that is not possible, [...
The US Food and Drug Administration (FDA) has approved canakinumab (Ilaris) injection for the treatment of active Still’s Disease, including adult-onset Still’s Disease (AOSD). “Prior to today’s approval, patients had no FDA-approved treatments for their disease, which can include symptoms such as...
The American College of Rheumatology (ACR) has published new guidelines for the management of gout. The updated guideline, published in Arthritis Care...
Autoimmunity appears to be increasing in the United States, according to a study published in Arthritis and Rheumatology. Frederick Miller, MD, National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health, Bethesda, Maryland, and colleagues found that the...
Use of low-dose methotrexate is associated with small to moderate elevations in risks for skin cancer and gastrointestinal, infectious, pulmonary, and haematologic adverse events, according to a study published in the Annals of Internal Medicine. Methotrexate is the most commonly used drug for...

Conference Reports

By Eric Ramos

CHICAGO -- June 12, 2020 -- An intra-articular injection of JTA-004, a novel enhanced protein solution that is supplemented with hyaluronic acid and clonidine, improved pain in patients with knee osteoarthritis, according to a study presented at the 2020 Virtual Meeting of...

By Eric Ramos

CHICAGO -- June 11, 2020 -- A set of antibody biomarkers can help predict which patients with rheumatoid arthritis (RA) will respond to therapy, according to a study presented at the 2020 Virtual Meeting of the European League Against Rheumatism (EULAR).

“For...

By Eric Ramos

CHICAGO -- June 9, 2020 -- Long-term treatment with canakinumab was safe and effective for patients with colchicine-resistant familial Mediterranean fever, according to a study presented at the 2020 Virtual Meeting of the European League Against Rheumatism (EULAR).

“...

By Eric Ramos

CHICAGO -- June 9, 2020 -- Therapeutic drug monitoring in patients with rheumatic diseases who are starting treatment with infliximab does not appear to be superior to standard treatment in order to achieve remission, according to a study presented at the 2020 Virtual...

By Eric Ramos

CHICAGO -- June 8, 2020 -- Colchicine 1 mg/day for 12 weeks was not effective in improving pain, tender and swollen joint count, or grip strength in patients with symptomatic hand osteoarthritis, according to a study presented at the 2020 Virtual Meeting of the European...

Recently Published

Pediatric Infectious Disease Journal
Adriana Maria Paixao De Sousa Da Silva, Maria Isabel De Moraes-Pinto, Regina Célia Menezes Succi, Maria Teresa Terreri, Daisy Maria Machado
Expert Opinion on Biological Therapy
Maria Sole Chimenti, Giulia Lavinia Fonti, Paola Conigliaro, Flavia Sunzini, Rossana Scrivo, Luca Navarini, Paola Triggianese, Giusy Peluso, Palma Scolieri, Rosalba Caccavale, Andrea Picchianti Diamanti, Erica De Martino, Simonetta Salemi, Domenico Birra, Alessio Altobelli, Marino Paroli, Vincenzo Bruzzese, Bruno Laganà, Elisa Gremese, Fabrizio Conti, Antonella Afeltra, Roberto Perricone
Clinical and Experimental Rheumatology
Ariela Hoxha, Elena Mattia, Anna Zanetti, Greta Carrara, Nathalie Morel, Nathalie Costedoat-Chalumeau, Antonio L Brucato, Amelia Ruffatti
Clinical and Experimental Rheumatology
Fang-Yuan Hu, Jia Wang, Sheng-Xiao Zhang, Rui Su, Ning Yan, Chong Gao, Xiao-Feng Li, Cai-Hong Wang
Clinical and Experimental Rheumatology
Salvatore Scarpato, Giuliana Galassi, Giuseppe Monti, Cesare Mazzaro, Maria Teresa Mascia, Patrizia Scaini, Davide Filippini, Maurizio Pietrogrande, Massimo Galli, Italian Group for the Study of Cryoglobulinaemia (GISC)

Full-Text Articles

Annals of the Rheumatic Diseases (ARD Online)
Seza Ozen, Eldad Ben-Cherit, Ivan Foeldvari, Gil Amarilyo, Huri Ozdogan, Steven Vanderschueren, Katherine Marzan, J Michelle Kahlenberg, Elise Dekker, Fabrizio De Benedetti, Isabelle Koné-Paut
Reumatología Clinica
Iván Posso-Osorio, Ivana Nieto-Aristizábal, Danny Soto, Camila Ariza, Mónica Urbano, Carlos A Cañas, Alex Echeverri, Alejandro Castillo, Gabriel J Tobón
Reumatología Clinica
Juan Sebastián Segura-Charry, Maria Alexandra Parada-Martinez, Hugo Ramiro Segura-Puello, Diana Milena Muñoz-Forero, Diana Lorena Nieto-Mosquera, Andrea Catalina Villamil-Ballesteros, Ani Julieth Cortés-Muñoz
Arthritis Research & Therapy
D Vedder, M Gerritsen, B Duvvuri, R F van Vollenhoven, M T Nurmohamed, C Lood